Emergent BioSolutions Management
Management Kriterienprüfungen 1/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Wichtige Informationen
Joe Papa
Geschäftsführender
n/a
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | n/a |
| Amtszeit als Geschäftsführer | less than a year |
| Eigentum des Geschäftsführers | n/a |
| Durchschnittliche Amtszeit des Managements | 1.6yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 3.2yrs |
Jüngste Management Updates
Recent updates
Little Excitement Around Emergent BioSolutions Inc.'s (NYSE:EBS) Revenues As Shares Take 27% Pounding
Sep 16
Emergent BioSolutions: Speculative Buy Amid Potential Monkeypox Vaccine Approval
Aug 18Emergent BioSolutions Inc. (NYSE:EBS) Held Back By Insufficient Growth Even After Shares Climb 41%
Aug 02Emergent BioSolutions: A Much-Needed Mid-Stage Turnaround In Process
Jul 15Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
May 10New CEO Appointment A Clear Positive For Emergent BioSolutions
Feb 27Emergent BioSolutions: Q3 Numbers Leave Work To Be Done
Dec 18Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow
Nov 23Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial
Aug 23Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade)
Aug 14Emergent BioSolutions: Making A Big Bet On Narcan
Jul 21An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 30% Undervalued
Jun 22Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?
Apr 05Emergent Biosolutions Q4 2022 Earnings Preview
Feb 24An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 39% Undervalued
Feb 16Emergent BioSolutions to offload travel health business to Bavarian Nordic for $380M
Feb 15Emergent BioSolutions: No Change To Thesis Following Latest Numbers, Recent Developments
Dec 07Emergent plunges 30% on quarterly earnings miss, lowers full-year guidance
Nov 09Emergent doses first participant in Phase 1 trial for Lassa virus vaccine
Sep 06Emergent BioSolutions: Now Long Through Sale Of October Put Spreads
Aug 24Geschäftsführer
Joe Papa (68 yo)
less than a year
Amtszeit
Mr. Joseph C. Papa, Jr. also known as Joe, is Director of Milestone Pharmaceuticals Inc. since September 3, 2024. Mr. Papa serves as Executive Advisor at Water Street Healthcare Partners, LLC since joining...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Executive VP | 6.5yrs | US$2.18m | 0.29% $ 1.2m | |
| Executive Vice President of Global Quality and Ethics & Compliance | 2.4yrs | US$1.68m | 0.30% $ 1.2m | |
| Senior Vice President of Products Business | 1.7yrs | US$1.06m | 0.045% $ 182.2k | |
| CEO, President & Director | less than a year | keine Daten | keine Daten | |
| Corporate Secretary and Interim General Counsel | less than a year | keine Daten | keine Daten | |
| Senior VP & Chief Human Resource Officer | 1.5yrs | keine Daten | keine Daten | |
| Senior VP | 1.5yrs | keine Daten | keine Daten | |
| Senior VP of Science & Development | 1.7yrs | keine Daten | keine Daten | |
| Senior Vice President of Manufacturing & Bioservices | no data | keine Daten | 0.089% $ 360.3k |
1.6yrs
Durchschnittliche Betriebszugehörigkeit
58.5yo
Durchschnittliches Alter
Erfahrenes Management: EBSDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.5 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO, President & Director | less than a year | keine Daten | keine Daten | |
| Independent Director | 18.3yrs | US$400.23k | 0.099% $ 400.1k | |
| Independent Director | 19.7yrs | US$394.73k | 0.037% $ 148.6k | |
| Independent Director | less than a year | US$397.50k | keine Daten | |
| Independent Director | 2.4yrs | US$396.99k | 0.011% $ 42.9k | |
| Independent Director | 3.9yrs | US$405.98k | 0.032% $ 128.1k | |
| Independent Non-Executive Chairman | 20.1yrs | US$535.98k | 0.070% $ 285.0k | |
| Independent Director | 7.8yrs | US$413.48k | 0.069% $ 277.5k | |
| Independent Director | less than a year | US$398.75k | keine Daten | |
| Independent Director | 2.2yrs | US$382.23k | 0.0073% $ 29.6k |
3.2yrs
Durchschnittliche Betriebszugehörigkeit
65yo
Durchschnittliches Alter
Erfahrener Vorstand: EBSDie Vorstandsmitglieder gelten als erfahren (3.1 Jahre durchschnittliche Amtszeit).